Quick answer
Avoid counterfeits
What Wegovy is & how it works
Wegovy is the same active ingredient as Ozempic — semaglutide — but titrated to a higher target dose (2.4 mg weekly) and registered for weight management rather than diabetes. That makes it the on-label choice for weight loss in SA, where Ozempic use for weight loss is off-label. The mechanism is identical: appetite reduction, slower gastric emptying and steadier blood sugar.
See Ozempic vs Wegovy for the practical differences, and Wegovy vs Mounjaro if you're weighing it against tirzepatide.
Who it's for
Wegovy is generally considered for adults with a BMI of 30 or more, or 27 or more with a weight-related condition (such as type 2 diabetes, high blood pressure or sleep apnoea), as part of a wider plan that includes diet and activity. It isn't suitable for everyone — for example in pregnancy, or with certain personal/family histories of medullary thyroid cancer or MEN 2.
Eligibility is a clinical decision. Check the thresholds in am I eligible? or try the private BMI calculator. Book a consultation with a registered provider
Realistic results
Wegovy's evidence is the STEP programme. In STEP 1, adults without diabetes lost about 15% of body weight on average over 68 weeks at the 2.4 mg dose, with roughly a third losing 20% or more. Because Wegovy reaches a higher dose than Ozempic, average weight loss is typically a little greater than Ozempic for the same person.
These are trial averages alongside lifestyle changes — not guarantees.
Side effects & safety
The most common side effects of Wegovy are gastrointestinal — nausea, constipation, diarrhoea and reflux — usually worst at the start or after a dose increase, and easing over time. Slow titration and simple diet adjustments help a lot.
Less common but serious risks include pancreatitis and gallbladder problems. Our full side effects & management guide explains what to expect and when to seek help.
When to seek help
Wegovy price in South Africa
Novo Nordisk cut Wegovy prices in March 2026. Rises with each dose step. Prices vary between Dis-Chem, Clicks and Medirite, and change often.
| Medicine | Dose | Typical / month | Note |
|---|---|---|---|
| WegovySemaglutide | 0.25 mg (starting) | R1,800 – R1,900 | Prices fell after the March 2026 cut. |
| WegovySemaglutide | 1.0 – 1.7 mg | R2,400 – R3,200 | Titration phase. |
| WegovySemaglutide | 2.4 mg (maintenance) | R3,400 – R3,800 | Full weight-management dose. |
Remember the hidden costs: the consultation (from ~R250 via telehealth), baseline and follow-up bloods, needles and cold-chain delivery. Your monthly cost also rises as the dose steps up.
Medical-aid cover
For weight loss, most South African schemes do not fund Wegovy as a chronic benefit, because obesity isn't a Prescribed Minimum Benefit. Some plans allow payment from a medical savings account or day-to-day benefit. See the scheme-by-scheme breakdown in medical-aid cover.
How to get Wegovy in South Africa
Wegovy is a Schedule 4 medicine — you need a prescription from a registered doctor, and you should only get the medicine from a licensed pharmacy. The usual routes are an in-person GP or a reputable telehealth service (online scripts from around R250), with the medicine dispensed or couriered to you under cold chain. A provider will check your eligibility, start you on a low dose and titrate up.
Avoid anyone offering Wegovy without a prescription or at prices that look too good — SAHPRA has warned about falsified semaglutide circulating in SA.
Next step